Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://medicaldialogues.in/nephrology/news/sglt2-inhibitors-lower-chronic-kidney-disease-risk-in-diabetes-patients-with-higher-dcsi-study-104442
0
0
SGLT2 inhibitors lower chronic kidney disease risk in diabetes patients with higher DCSI: Study - Medical Dialogues
1/6/23 at 2:30pm
Organization
Medical Dialogues
Author
Medha Baranwal
Details
45 words
Summarize
Diabetes
Endocrine Conditions
Health
DCSI
chronic kidney disease risk
SGLT2
SGLT2Is
Study - Medical Dialogues Taiwan
Taiwan: The use of sodium-glucose cotransporter-2 inhibitors (SGLT2Is) significantly lowers the risk of chronic kidney disease (CKD) in type 2 diabetes patients with a higher DCSI (diabetes...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...